See also this year's filing and all EDGAR filings for this company.
PDF Report 0000810509_2020_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Revenues', 'missing_ratio': 0.00030045187962695897, 'aggregate_val': 915013, 'exp_sum': 915288, 'exp_to_value': {'remainder_Revenues': 915288}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000810509')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 512,344 |
| 1 | LiabilitiesCurrent | 3,819,551 |
| 2 | remainder_Liabilities | 700,000 |
| 3 | AssetsCurrent | 2,915,783 |
| 4 | AssetsNoncurrent | 819,500 |
| 5 | PropertyPlantAndEquipmentNet | 30,210 |
| 6 | Goodwill | 385,413 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 6,282,076 |
| 9 | ResearchAndDevelopmentExpense | 5,338,267 |
| 10 | remainder_Expenses | 707 |
| 11 | remainder_Revenues | 657,826 |
| 12 | remainder_NetIncome | 15,010 |
| 13 | remainder_ComprehensiveNetIncome | 730 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 5,031,895 |
| 1 | Assets | 4,150,906 |
| 2 | Expenses | 11,621,050 |
| 3 | Revenues | 657,826 |
| 4 | StockholdersEquity | -880,989 |
| 5 | NetIncome | -10,948,214 |
| 6 | ComprehensiveNetIncome | -10,947,849 |
| 7 | BaseVar | 10,738,708 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.65 |
| 9 | EconomicCapitalRatio | 0.178 |
Edgar->Model Mapping
Feature Distribution
Change over Time
